Skip to content
OpenCapital
Get started

QuidelOrtho Corporation QDEL Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%—

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's stock issuance proceeds?
QuidelOrtho Corporation (QDEL) reported stock issuance proceeds of $1.8M in Q1 2026.
How has QuidelOrtho Corporation's stock issuance proceeds changed year-over-year?
QuidelOrtho Corporation's stock issuance proceeds decreased by 40.0% year-over-year, from $3M to $1.8M.
What is the long-term trend for QuidelOrtho Corporation's stock issuance proceeds?
Over 3 years (2022 to 2025), QuidelOrtho Corporation's stock issuance proceeds has grown at a -38.6% compound annual growth rate (CAGR), from $26.4M to $6.1M.
What does stock issuance proceeds mean?
Represents the total cash inflows received from the issuance of common equity to investors or employees. This metric reflects the company's ability to raise capital through equity markets or the exercise of stock-based compensation plans.